Výsledky vyhľadávania - "TRIPLE-negative breast cancer"

Ameliorative effects of tocilizumab on lung and liver metastatic lesions.

Autori: Kizilates, Ceren Ozmen, Ozlem Aslan Kosar, Pınar a ďalší

Zdroj: Mediterranean Veterinary Journal. Aug2025, Vol. 10 Issue 2, p486-495. 10p.

Predmet: Triple-negative breast cancer, Breast cancer, Cisplatin, Tocilizumab, Tumor microenvironment

Annonacin induces apoptosis and modulates programmed death-ligand 1 and interferon-gamma expression in triple-negative breast cancer: Integrated in silico and in vitro analysis.

Autori: Yunani, Retina Sudjarwo, Sri Agus Effendi, Mustofa Helmi a ďalší

Zdroj: Veterinary World. Aug2025, Vol. 18 Issue 8, p2241-2251. 11p.

Predmet: Triple-negative breast cancer, Programmed death-ligand 1, Immunoregulation, In vitro studies, Molecular docking, Apoptosis, Antineoplastic agents, Interferon gamma

Omomyc as a novel therapeutic strategy against metastatic triple-negative breast cancer, alone and in combination with the standard of care

Autori: Giuntini, Fabio

Thesis Advisors: Soucek , Laura, Massó Vallès, Daniel

Zdroj: TDX (Tesis Doctorals en Xarxa)

Predmety: Càncer de mama triple negatiu, Triple-negative breast cancer, Cáncer de mama triple negativo, MYC, Ciències de la Salut

Popis súboru: application/pdf

Prístupová URL adresa: http://hdl.handle.net/10803/694828

Phenyl boronic acid conjugated lipid nanoparticles for targeted delivery of gamma-secretase inhibitor to breast cancer cells.

Autori: Gummadi, Ramakrishna Nori, Lakshmi Prasanthi Pindiprolu, Sai Kiran S. S.

Zdroj: Drug Development & Industrial Pharmacy. Jul2025, Vol. 51 Issue 7, p811-825. 15p.

Predmety: TRIPLE-negative breast cancer, TARGETED drug delivery, CANCER stem cells, BORONIC acids, BREAST cancer

Apoptotic and anti-migratory effects of Achillea millefolium dichloromethane extract on MDA-MB-231 human breast cancer cells.

Autori: Qurtam, A. A. Nasr, F. A.

Zdroj: Journal of Animal & Feed Sciences. 2024, Vol. 33 Issue 4, p469-477. 9p.

Predmet: Triple-negative breast cancer, Common yarrow, p53 protein, Breast cancer, Polymerase chain reaction, Gas chromatography/Mass spectrometry (GC-MS)

Dual functioning Ru(II)/Ir(III) complexes for ferroptosis and apoptosis in triple-negative breast cancer: a proof of concept by glutathione depletion.

Autori: Das, Utpal Dasgupta, Tiasha Santhoshkumar, Krishna a ďalší

Zdroj: Dalton Transactions: An International Journal of Inorganic Chemistry. 12/14/2025, Vol. 54 Issue 46, p17162-17179. 18p.

Predmety: *TRIPLE-negative breast cancer, *APOPTOSIS, *CASPASES regulation, *RUTHENIUM compounds, *REACTIVE oxygen species, *CELL death, *MITOCHONDRIA, *GLUTATHIONE

Tussilagone suppresses triple-negative breast cancer progression by inhibiting the TLR4/NF-κB pathway and enhancing anti-tumor immunity.

Autori: Huang, Rui Yu, Hao Tang, Zhimou

Zdroj: Immunopharmacology & Immunotoxicology. Dec2025, Vol. 47 Issue 6, p740-750. 11p.

Predmety: *TRIPLE-negative breast cancer, *TUMOR microenvironment, *IMMUNE response, *PHYTOCHEMICALS, *EPITHELIAL-mesenchymal transition, *CELLULAR signal transduction, *ANIMAL models in research

Future perspective of clinical usefulness of metabolic and mitochondrial heterogeneity in triple-negative breast cancers.

Autori: Li, Jing Velaga, Ravi Takano, Yuko a ďalší

Zdroj: International Journal of Clinical Oncology. Dec2025, Vol. 30 Issue 12, p2399-2409. 11p.

Predmety: *TRIPLE-negative breast cancer, *MITOCHONDRIA, *IMMUNOSUPPRESSION, *LIPID metabolism, *OXIDATIVE phosphorylation, *THERAPEUTICS, *GLYCOLYSIS

Risk of severe infections in patients with triple-negative breast cancer treated with atezolizumab plus nab-paclitaxel: a real-world, postmarketing database study in Japan.

Autori: Yuri, Akinori Nakane, Sayuri Miyano, Yuki a ďalší

Zdroj: International Journal of Clinical Oncology. Dec2025, Vol. 30 Issue 12, p2541-2548. 8p.

Predmety: *TRIPLE-negative breast cancer, *ATEZOLIZUMAB, *PACLITAXEL, *FIELD research, *DISEASE prevalence, *PHARMACEUTICAL technology, *INFECTION

Geografický termín: JAPAN

Sacituzumab govitecan in HER2-negative breast cancer: redefining treatment paradigms.

Autori: Khadela, Avinash Morakhia, Kashvy R. Shah, Nishra H. a ďalší

Zdroj: Journal of Drug Targeting. Dec2025, Vol. 33 Issue 10, p1743-1756. 14p.

Predmety: *TRIPLE-negative breast cancer, *ANTIBODY-drug conjugates, *CLINICAL trials, *OVERALL survival, *HORMONE receptors, *MEDICAL protocols

κ-Opioid receptor activation suppresses triple-negative breast cancer progression by inducing urea cycle dysfunction and mitochondrial damage in vitro and in mice.

Autori: Shi, Yumiao Tao, Yiying Pan, Zhiying a ďalší

Zdroj: BJA: The British Journal of Anaesthesia. Dec2025, Vol. 135 Issue 6, p1803-1815. 13p.

Predmety: *TRIPLE-negative breast cancer, *OPIOID receptors, *MITOCHONDRIAL pathology, *CANCER invasiveness, *APOPTOSIS, *METABOLOMICS

Vinpocetine Overcomes Paclitaxel Resistance in a Triple‐Negative Breast Cancer Cell Line.

Autori: Kuo, Hsiao‐Hui Huang, Chien‐Wei Chiang, Wei‐Rou a ďalší

Zdroj: Cell Biology International. Dec2025, Vol. 49 Issue 12, p1716-1729. 14p.

Predmety: *TRIPLE-negative breast cancer, *DRUG resistance, *PACLITAXEL, *MICROTUBULES, *PHOSPHODIESTERASES, *P-glycoprotein, *NOOTROPIC agents

Epimedokoreanin B blocks autophagic flux to inhibit progression of triple negative breast cancer through targeting MCOLN1/TRPML1 channel.

Autori: Zhao, Chenyang Zhang, Peng Yang, Xiaojuan a ďalší

Zdroj: Free Radical Biology & Medicine. Dec2025, Vol. 240, p222-237. 16p.

Predmety: *TRIPLE-negative breast cancer, *AUTOPHAGY, *ION channels, *OXIDATIVE stress, *APOPTOSIS, *TUMOR-infiltrating immune cells

CLIC3 emerges as a novel prognostic biomarker and therapeutic target in triple-negative breast cancer through integrated multi-omics analysis.

Autori: Yuan, Shuai Li, Jiangxia Liu, Weimei a ďalší

Zdroj: BMC Cancer. 11/26/2025, Vol. 25 Issue 1, p1-16. 16p.

Predmety: *TRIPLE-negative breast cancer, *PROGNOSIS, *MULTIOMICS, *DRUG target, *DNA sequencing, *PROTEIN expression, *OVERALL survival, *RNA sequencing

Antiproliferative effect of Filopaludina bengalensis fluid inducing apoptosis-necroptosis synergy with immunogenic remodelling in triple-negative breast cancer.

Autori: Mangal, Sudipto Jana, Sumit Dutta, Ananya a ďalší

Zdroj: Scientific Reports. 11/25/2025, Vol. 15 Issue 1, p1-13. 13p.

Predmety: *TRIPLE-negative breast cancer, *APOPTOSIS, *NECROSIS, *IMMUNE response, *MOLLUSKS, *REACTIVE oxygen species, *ANTINEOPLASTIC agents

Single‐cell transcriptome analysis reveals macrophage‐specific apolipoprotein C1 as a key regulator of polarization and progression in triple‐negative breast cancer.

Autori: Xu, Mei Jin, HuaLong Yang, Fan a ďalší

Zdroj: Immunology & Cell Biology. Nov2025, p1. 13p. 5 Illustrations.

Predmety: *MACROPHAGES, *TRIPLE-negative breast cancer, *IMMUNOTHERAPY, *CELL differentiation, *CANCER invasiveness, *APOLIPOPROTEIN C, *CELL analysis, *GLYCOLYSIS

Targeting SOX9: designing a novel vaccine against triple-negative breast cancer.

Autori: Hatamian, Ghazaleh Ebrahimpour, Amirali Nejabat, Mojgan a ďalší

Zdroj: Scientific Reports. 11/24/2025, Vol. 15 Issue 1, p1-17. 17p.

Predmety: *TRIPLE-negative breast cancer, *VACCINES, *SOX transcription factors, *EPITOPES, *IMMUNOTHERAPY, *MOLECULAR docking, *IMMUNE response

Safety and efficacy of immune checkpoint inhibitors in patients with triple-negative breast cancer: a systematic review and meta-analysis.

Autori: Yan, Xin Zhang, Xiaoling Wang, Zengyan a ďalší

Zdroj: BMC Cancer. 11/22/2025, Vol. 25 Issue 1, p1-15. 15p.

Predmety: *TRIPLE-negative breast cancer, *IMMUNE checkpoint inhibitors, *SAFETY, *CLINICAL trials, *SURVIVAL rate, *ADVERSE health care events, *TREATMENT effectiveness

ZNF526 drives tumor growth by enhancing SHMT1-dependent serine metabolism and antioxidant capability in TNBC.

Autori: Qin, Wenxing Shao, Lujing Li, Qi a ďalší

Zdroj: Molecular Cancer. 11/20/2025, Vol. 24 Issue 1, p1-19. 19p.

Predmety: *TRIPLE-negative breast cancer, *TUMOR growth, *AMINO acid metabolism, *METABOLIC regulation, *ONCOGENES, *ANTIOXIDANTS

Triple‐Negative Male Breast Cancer Presenting as Cutaneous Metastasis: A Diagnostic Rarity.

Autori: Ajai Mokan Dasan, Saran Lal Pandey, Neelanjana Sukhoroslov, Mikhail a ďalší

Zdroj: Case Reports in Oncological Medicine. 11/20/2025, Vol. 2025, p1-7. 7p.

Predmety: *MALE breast cancer, *TRIPLE-negative breast cancer, *MEDICAL literature, *TUMORS, *DIAGNOSIS, *METASTASIS